Commonwealth Biotechnologies, Inc. Issues Corrected Safe Harbor Declaration

Business Wire, Nov 23, 2004

RICHMOND, Va. -- On November 19, 2004 Commonwealth Biotechnologies, Inc. (NASDAQ: CBTE), issued a press release detailing its acquisition of Fairfax Identity Labs (FIL), a division of Genetics & IVF Institute, Inc. Fairfax, VA. This press release inadvertently contained an incorrect Safe Harbor declaration. Hence, Commonwealth Biotechnologies is issuing this corrected Safe Harbor declaration, relative to the FIL acquisition:

Corrected SAFE HARBOR Declaration: No statement made in this press release should be interpreted as an offer to purchase any security. Such an offer can only be made in accordance with the Securities Act of 1933, as amended, and applicable state securities laws. Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties as identified in the Company's filings with the Securities and Exchange Commission. Actual results, events or performance may differ materially. Readers are cautioned not to place undo reliance on these forward-looking statements, which speak only as the date hereof. CBI cannot guaranty that the acquisition of FIL will produce any revenues or prospects referenced herein, or that CBI will be able to successfully continue the business practices of FIL. In addition, CBI cannot guaranty that it will effectively compete for any additional federal funds that may be utilized in any programs referenced herein. The Company undertakes no obligation to publicly release the results of any revisions to these forward looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

About CBI

Founded in 1992, CBI is located in Gateway Centre, Chesterfield County at 601 Biotech Drive, 23235 (1-800-735-9224). For more information, visit CBI on the web at www.cbi-biotech.com.